{"id":47689,"date":"2022-08-26T02:01:37","date_gmt":"2022-08-26T00:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/"},"modified":"2022-08-26T02:01:37","modified_gmt":"2022-08-26T00:01:37","slug":"henry-schein-to-present-at-two-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/","title":{"rendered":"Henry Schein to Present at Two Investor Conferences in September"},"content":{"rendered":"<div>\n<p>MELVILLE, N.Y.&#8211;(BUSINESS WIRE)&#8211;Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/5\/HenrySchein_2000x374-BW.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMorgan Stanley 20<sup>th<\/sup> Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 a.m. Eastern time.\n<\/li>\n<li>\nBaird 2022 Global Healthcare Conference at the InterContinental New York Barclay on September 14, 2022, at 10:15 a.m. Eastern time.\n<\/li>\n<\/ul>\n<p>\nHenry Schein\u2019s presentations can be heard via live webcast by visiting <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.henryschein.com%2FIRwebcasts&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=www.henryschein.com%2FIRwebcasts&amp;index=1&amp;md5=1897b98be795d5d2fb99e9217c1fa4b3\" rel=\"nofollow noopener\" shape=\"rect\">www.henryschein.com\/IRwebcasts<\/a>. Replays will be available on the Henry Schein website following the presentations.\n<\/p>\n<p>\n<b>About Henry Schein, Inc.<\/b>\n<\/p>\n<p>\nHenry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.henryschein.com%2Fus-en%2FCorporate%2FCulture.aspx%3Futm_source%3DCorporate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26utm_term%3DTeamScheinMembers%26cdivid%3Dcorporate&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=Team+Schein+Members&amp;index=2&amp;md5=cdc442df928e5c2d0a697469b232cf77\" rel=\"nofollow noopener\" shape=\"rect\">Team Schein Members<\/a> worldwide, the Company&#8217;s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.henryschein.com%2Fus-en%2Fdental%2FDefault.aspx%3Fdid%3Ddental%26stay%3D1%26utm_source%3DCorportate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26utm_term%3Ddental%26cdivid%3Ddental&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=dental&amp;index=3&amp;md5=03ccf969108a3e9b8d22b642c3ed866c\" rel=\"nofollow noopener\" shape=\"rect\">dental<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.henryschein.com%2Fus-en%2Fmedical%2Fdefault.aspx%3Fdid%3Dmedical%26stay%3D1%26utm_source%3DCorportate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26utm_term%3Dmedical%26cdivid%3Dmedical&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=medical&amp;index=4&amp;md5=eac511fcd2a50bf99c256396222deb2b\" rel=\"nofollow noopener\" shape=\"rect\">medical<\/a> practitioners work more efficiently so they can provide quality care more effectively. These solutions also support <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.henryschein.com%2Fus-en%2Fzahn%2Fhome.aspx%3Futm_source%3DCorporate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26utm_term%3DZahn%26cdivid%3Dzahn&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=dental+laboratories&amp;index=5&amp;md5=4c346cbe7c5d6c76d6839d6e2cf0fb0d\" rel=\"nofollow noopener\" shape=\"rect\">dental laboratories<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.henryschein.com%2Fus-en%2Fspecialmarkets%2FDefault.aspx%3Futm_source%3DCorporate%26utm_medium%3DExternal%26utm_campaign%3DBoilerPlateLinks%26utm_term%3DGovernmentInstitutional%26cdivid%3Dspecialmarkets_d&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=government+and+institutional+health+care+clinics&amp;index=6&amp;md5=09ec1f7d0eb5345a4d057791bc6b3403\" rel=\"nofollow noopener\" shape=\"rect\">government and institutional health care clinics<\/a>, as well as other alternate care sites.\n<\/p>\n<p>\nHenry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.\n<\/p>\n<p>\nA FORTUNE 500 Company and a member of the S&amp;P 500\u00ae index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company&#8217;s sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.\n<\/p>\n<p>\nFor more information, visit Henry Schein at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.henryschein.com&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=www.henryschein.com&amp;index=7&amp;md5=92b3e8de86ffca9000df951f169c57b7\" rel=\"nofollow noopener\" shape=\"rect\">www.henryschein.com<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fhenryschein%2F&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=Facebook.com%2FHenrySchein&amp;index=8&amp;md5=d7cd7283f42cdfa494841aee7d5ccaba\" rel=\"nofollow noopener\" shape=\"rect\">Facebook.com\/HenrySchein<\/a>, and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FHenrySchein&amp;esheet=52830437&amp;newsitemid=20220825005730&amp;lan=en-US&amp;anchor=%40HenrySchein+on+Twitter&amp;index=9&amp;md5=c8b97c416af66c8a06952b0093dd6730\" rel=\"nofollow noopener\" shape=\"rect\">@HenrySchein on Twitter<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<span class=\"bwuline\">Investors<\/span><br \/>Ronald N. South<br \/>\n<br \/>Senior Vice President and Chief Financial Officer<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;r&#x6f;&#110;a&#x6c;&#100;&#x2e;&#x73;o&#x75;&#116;h&#x40;&#104;e&#x6e;&#114;&#x79;&#x73;&#99;&#x68;&#x65;i&#x6e;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">rona&#108;&#100;&#46;&#115;&#111;&#x75;&#x74;&#x68;&#x40;&#x68;&#x65;&#x6e;rysc&#104;&#101;&#105;&#110;&#46;&#x63;&#x6f;&#x6d;<\/a><br \/>(631) 845-2802\n<\/p>\n<p>\nGraham Stanley<br \/>\n<br \/>Vice President, Investor Relations and Strategic Financial Project Officer<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x67;r&#97;&#x68;&#97;&#x6d;&#46;&#x73;t&#x61;n&#108;&#x65;&#121;&#x40;&#104;&#x65;&#110;&#x72;y&#x73;c&#104;&#x65;&#105;&#x6e;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">grah&#97;&#109;&#46;&#115;&#116;&#97;&#110;&#x6c;&#x65;&#x79;&#x40;&#x68;&#x65;&#x6e;&#x72;&#x79;sche&#105;&#110;&#46;&#99;&#111;&#109;<\/a><br \/>(631) 843-5963\n<\/p>\n<p>\n<span class=\"bwuline\">Media<\/span><br \/>Ann Marie Gothard<br \/>\n<br \/>Vice President, Global Corporate Media Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x61;&#x6e;&#x6e;&#x6d;&#x61;&#x72;&#x69;&#x65;&#x2e;&#x67;&#x6f;&#x74;&#x68;&#x61;&#x72;&#x64;&#x40;&#x68;&#x65;&#x6e;&#x72;&#x79;&#x73;&#x63;&#x68;&#x65;&#x69;&#x6e;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#110;n&#x6d;&#x61;&#114;i&#x65;&#46;g&#x6f;&#x74;&#104;a&#x72;&#100;&#64;&#x68;&#x65;&#110;r&#x79;&#x73;&#99;&#x68;&#x65;&#105;n&#x2e;&#x63;&#111;m<\/a><br \/>(631) 390-8169\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>MELVILLE, N.Y.&#8211;(BUSINESS WIRE)&#8211;Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47689","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Henry Schein to Present at Two Investor Conferences in September - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Henry Schein to Present at Two Investor Conferences in September - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MELVILLE, N.Y.&#8211;(BUSINESS WIRE)&#8211;Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-26T00:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Henry Schein to Present at Two Investor Conferences in September\",\"datePublished\":\"2022-08-26T00:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/\"},\"wordCount\":374,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005730\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374-BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/\",\"name\":\"Henry Schein to Present at Two Investor Conferences in September - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005730\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374-BW.jpg\",\"datePublished\":\"2022-08-26T00:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005730\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374-BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220825005730\\\/en\\\/723981\\\/21\\\/HenrySchein_2000x374-BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/henry-schein-to-present-at-two-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Henry Schein to Present at Two Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Henry Schein to Present at Two Investor Conferences in September - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Henry Schein to Present at Two Investor Conferences in September - Pharma Trend","og_description":"MELVILLE, N.Y.&#8211;(BUSINESS WIRE)&#8211;Henry Schein, Inc. (Nasdaq: HSIC), the world\u2019s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in September: Morgan Stanley 20th Annual Global Healthcare Conference at the Grand Hyatt in New York on September 12, 2022, at 9:20 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-26T00:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Henry Schein to Present at Two Investor Conferences in September","datePublished":"2022-08-26T00:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/"},"wordCount":374,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/","url":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/","name":"Henry Schein to Present at Two Investor Conferences in September - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg","datePublished":"2022-08-26T00:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220825005730\/en\/723981\/21\/HenrySchein_2000x374-BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/henry-schein-to-present-at-two-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Henry Schein to Present at Two Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47689"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47689\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}